3D Telemedicine: A Clinician Feedback Study

3D Telemedicine: Communication During Covid 19. A Clinician Feedback Study

The use of Telemedicine has increased significantly due to constraints imposed by the Covid pandemic. 3D telemedicine uses multiple cameras in the clinic room which can reconstruct an image in 3 dimensions in real-time, which may be beneficial in more visual focused specialties such as Plastic Surgery. There are no clinical data regarding the use of 3D telemedicine, with previous studies laboratory based without clinicians or patients. This study aims to provide clinician data comparing 3D and 2D Telemedicine, and feedback to allow incremental improvement of the system prior to clinical trials involving patients.

Study Overview

• Status: Completed
• Conditions: Telemedicine; Reconstructive Surgery; 3 Dimensional
• Intervention / Treatment: Other: 3D Telemedicine; Other: 2D Telemedicine

Detailed Description

Aims The aim of this study is to assess 3D telemedicine and 2D telemedicine from the clinician's perspective, to optimise the system prior to clinical trials with patients. This will provide baseline validated outcome data on areas such as usability, presence (the realism or immersion of a system), mental effort and task load. "Keep, Lose and Change" prompts will be used to aid improvements in the 3D Telemedicine system prior to clinical trials.

Participants This will be a clinician feedback based study on 2D telemedicine and 3D telemedicine. Clinicians will include nurses, doctors and physiotherapists from Canniesburn Plastic Surgery Unit, Glasgow, UK.

Consent Clinicians will consent in writing to participate

Method Clinicians will use both 3D and 2D Telemedicine systems to examine a member of the research team who will act as a "patient". There will be a single clinician (consultant, nurse specialist or physiotherapist) examining the patient during the clinic.They will use each system for 10 minutes each. No randomisation will take place. This will be followed by a questionnaire which will be filled in once per patient by the clinician in the clinic.

Outcome measures No primary or secondary measures are specified as this is an observational feedback study, not an interventional clinical trial.

Satisfaction - Visual Analogue Scale 0-100 Mental Effort Rating Scale - single instrument Likert scale (Paas 1996) System Usability Scale - 10 item industry standard technology scale Presence Questionnaire - 29 item scale - assessment of presence in the system/virtual environment (PQ, Witmer 2005).

Semi Structured exit interview - will discuss with participant their views on the telemedicine system, using "Keep, Lose and Change" prompts to aid system improvements.

• Study Type: Observational
• Enrollment (Actual): 23

Contacts and Locations

Study Locations

• United Kingdom
  • Scotland
    • Glasgow, Scotland, United Kingdom, G4 0SF
      • Canniesburn Regional Plastic Surgery and Burns Unit

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The study population will consist of a mix of clinicians from Canniesburn Plastic Surgery Unit including:

• doctors
• nurses
• physiotherapists These clinicians will be at varying levels of seniority, age and will be gender balanced, to provide generalisability of the results

Description

Inclusion Criteria:

• clinicians in Canniesburn Plastic Surgery Unit
• doctors
• nurses
• physiotherapists

Exclusion Criteria:

• visual problems whereby participant is legally blind
• cannot consent

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
3D Telemedicine; Clinical consultation conducted with 3D Telemedicine	Other: 3D Telemedicine; 3D Telemedicine system
2D Telemedicine; Clinical consultation conducted with 2D Telemedicine	Other: 2D Telemedicine; 2D Telemedicine system

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Clinical Satisfaction	Satisfaction measured on a Visual Analogue Scale between 0-100. Higher is better (Voutilainen et al. 2016).	1 day (Single time point post study)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
System Usability Scale	10 item industry standard technology scale, scores converted to a 0-100 scale. Higher is better	1 day (Single time point post study)
Presence Questionnaire	29 item scale - assessment of presence in the system/virtual environment. Score 0-203, Higher is better (PQ, Witmer 2005).	1 day (Single time point post study)
Mental Effort Rating Scale	Single instrument Likert scale rated 1-9. Lower is better (Paas 1996)	1 day (Single time point post study)

Collaborators and Investigators

• Sponsor: NHS Greater Glasgow and Clyde
• Collaborators: University of Strathclyde; Microsoft Corporation

Study record dates

Study Major Dates

• Study Start (Actual): November 11, 2020
• Primary Completion (Actual): December 16, 2020
• Study Completion (Actual): December 16, 2020

Study Registration Dates

• First Submitted: February 23, 2022
• First Submitted That Met QC Criteria: February 23, 2022
• First Posted (Actual): March 4, 2022

Study Record Updates

• Last Update Posted (Actual): May 31, 2022
• Last Update Submitted That Met QC Criteria: May 24, 2022
• Last Verified: February 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: GN20HS181

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: IPD available on reasonable written request

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No